Terbogrel
From Wikipedia, the free encyclopedia
Jump to: navigation, search
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (May 2010) (Learn how and when to remove this template message) |
Names | |
---|---|
IUPAC name
(5E)-6-{3-[tert-butyl(cyano)carbamimidamido]phenyl}-6-pyridin-3-ylhex-5-enoic acid
|
|
Identifiers | |
149979-74-8 N | |
ChEMBL | ChEMBL281398 Y |
ChemSpider | 4952549 Y |
Jmol 3D model | Interactive image |
KEGG | D06077 Y |
PubChem | 6449876 |
UNII | 5Z4KWQ5OGN Y |
|
|
|
|
Properties | |
C23H27N5O2 | |
Molar mass | 405.49 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
N verify (what is YN ?) | |
Infobox references | |
Terbogrel blocks thromboxanes and is expected to be useful in treating the vasoconstricting and platelet aggregating action of this compound. Terbogrel is a thromboxane A2 receptor antagonist.
See also[edit]
References[edit]
Antiplatelet drugs |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anticoagulants |
|
||||||||||||||||||||||||||
Thrombolytic drugs/ fibrinolytics |
|||||||||||||||||||||||||||
Non-medicinal | |||||||||||||||||||||||||||
|
Adrenergics, inhalants |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucocorticoids | |||||||||||||||
Anticholinergics/ muscarinic antagonist |
|||||||||||||||
Mast cell stabilizers | |||||||||||||||
Xanthines | |||||||||||||||
Eicosanoid inhibition |
|
||||||||||||||
Others/unknown | |||||||||||||||
Combination products | |||||||||||||||
|
Retrieved from "https://en.wikipedia.org/w/index.php?title=Terbogrel&oldid=670137564"